Unknown PHASE4 INTERVENTIONAL 2-arm NCT02910765

Methylene Blue and Ozone in Early Sepsis

Methylene Blue and Ozone in Early Sepsis , a Randomized Double Blind Trial

Sponsor: Assiut University

Conditions Sepsis

Interventions methylene blue oxygen ozone saline infusion

Updated 6 times since 2017 Last updated: Sep 20, 2016 Started: Oct 31, 2016 Primary completion: Mar 31, 2017 Completion: Apr 30, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Sepsis and is currently ongoing. Assiut University leads this study, which shows 6 recorded versions since 2016 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Oct 2018 — Jan 2021 [monthly]

Unknown Status PHASE4

Status: Not Yet Recruiting → Unknown Status
Feb 2017 — Oct 2018 [monthly]

Not Yet Recruiting PHASE4

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Not Yet Recruiting PHASE4

First recorded

Oct 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Assiut University

Data source: Assiut University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.